Home > Insider Trading > Filing (0001250853-18-000113)

Filing Details

Accession Number:: 0001250853-18-000113
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-08-13 16:06:19
Reporting Period:: 2018-08-09

Accepted Time:: 2018-08-13 16:06:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270264	T Roy Eddleman	C/O Troygould Pc, 1801 Century Park E. 16Th Floor Los Angeles CA 90067		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-09	76,858	$49.67	720,000	No	4	S	Indirect	As trustee
Common Stock	Disposition	2018-08-09	39,215	$49.54	370,000	No	4	S	Indirect	As trustee

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	As trustee
No	4	S	Indirect	As trustee

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	357,518	Direct
Common Stock	2,903,466	Indirect	As trustee

Footnotes

The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.6450 to $49.6950, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price with the price ranges set forth in this footnote and in footnote (3), below.
The shares shown are held, of record, by a charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The price is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $49.4328 to $49.5959, inclusive.
The shares shown are held, of record, by a second charitable remainder unitrust of which the reporting person is the sole trustee and, as such, has investment and voting control over such shares, and is a lifetime beneficiary. The reporting person disclaims as beneficial ownership of the shares except to the extent of his pecuniary interest therein.
The shares shown are held for the benefit of the reporting person in a 15-month escrow account established in connection with the acquisition of Spectrum, Inc. by the issuer on August 1, 2017 and are subject to potential indemnification claims of the issuer relating to the acquisition.
The shares shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee, and as such, has investment and voting control over such shares.